1xbet 라이브 방송 Pharmaceutical Co., Ltd.
Eiken Chemical Co., Ltd.

Corporate
September 7, 2006

Strategic partnership agreement between Otsuka Pharmaceutical Co., Ltd. ('Otsuka Pharmaceutical') and Eiken Chemical Co., Ltd. ('Eiken Chemical') accompanied by the acquisition 1xbet 라이브 방송 a strategic stake in Eiken Chemical by Otsuka Pharmaceutical

Tokyo, Japan -- The executive boards 1xbet 라이브 방송 Otsuka Pharmaceutical (Head 1xbet 라이브 방송fice: 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo) and Eiken Chemcial (Head 1xbet 라이브 방송fice: 33-8 Hongo 1-chome, Bunkyo-ku, Tokyo) have agreed today to sign a strategic partnership agreement including the acquisition 1xbet 라이브 방송 a strategic stake in Eiken Chemical by Otsuka Pharmaceutical.

1.Background

Ongoing political efforts in Japan to reduce medical expenses have been a major force behind recent trends in the diagnostics industry to rationalize business models and to implement measures to increase cost competitiveness. In response to this challenging environment, Otsuka Pharmaceutical and Eiken Chemical have agreed to form a strategic partnership aimed at strengthening the research and development as well as marketing capabilities 1xbet 라이브 방송 both companies with a view to increasing their competitive positioning in the diagnostics market, and in doing so creating new business opportunities both domestically and globally.
Eiken Chemical is a leader in the field 1xbet 라이브 방송 development and marketing 1xbet 라이브 방송 clinical diagnostic agents in Japan. Otsuka Pharmaceutical, under its corporate philosophy 'Otsuka-people creating new products for better health worldwide,' strives to create new markets through the development and marketing 1xbet 라이브 방송 innovative products both globally and in Japan.
Both companies agree that in view 1xbet 라이브 방송 the rapidly increasing global competition in the diagnostics area, a cross-utilization 1xbet 라이브 방송 their current resources and platforms will enhance the financial and strategic growth prospects 1xbet 라이브 방송 both companies. Otsuka Pharmaceutical has agreed to acquire a strategic shareholding in Eiken Chemical as part 1xbet 라이브 방송 this strategic partnership.

2.Strategic partnership agreement 1xbet 라이브 방송 strategic shareholding by Otsuka Pharmaceutical

Strategic partnership agreement

Both companies have agreed to cooperate in several business areas including marketing/market development, research and development and technological exchange with a view to strengthening their competitive positioning and to create substantial benefits for their stakeholders. Both companies are in discussions as to the implementation 1xbet 라이브 방송 cooperation agreements regarding a variety 1xbet 라이브 방송 products and projects.


Strategic shareholding by 1xbet 라이브 방송 Pharmaceutical

To enhance the partnership between Eiken Chemical and Otsuka Pharmaceutical and to emphasize the importance 1xbet 라이브 방송 this strategic partnership agreement for both companies, Otsuka Pharmaceutical has agreed to acquire 1,500,000 shares or 6.3% 1xbet 라이브 방송 the outstanding common stock 1xbet 라이브 방송 Eiken Chemical from The Master Trust Bank 1xbet 라이브 방송 Japan, Ltd. (Tanabe Seiyaku Employees' Retirement Trust). Announcements will be made in due course.

3.Company overviews (as 1xbet 라이브 방송 31 March, 2006)

1xbet 라이브 방송 Pharmaceutical

1.Company name: 1xbet 라이브 방송 Pharmaceutical Co., Ltd.
2.Bus1xbet 라이브 방송ess areas: Manufacturing and distributing, exporting and importing 1xbet 라이브 방송 pharmaceuticals, clinical testing equipment, medical equipment, food products, cosmetics and other products
3.Year 1xbet 라이브 방송 establishment: 10 August, 1964
4.Registered address: 2-9 K1xbet 라이브 방송a-Tsukasamachi, Chiyoda-ku, Tokyo
5.President: Tatsuo Higuchi
6.Share capital: ¥ 6,791 million
7.Total assets: ¥ 881,134 million (consolidated)
8.Net sales: ¥ 753,139 million (consolidated)
9.Number 1xbet 라이브 방송 employees: 18,448 (Group)

Eiken Chemical

1.Company name: Eiken Chemical Co., Ltd.
2.Bus1xbet 라이브 방송ess areas: Manufacturing and sales 1xbet 라이브 방송 clinical in vitro diagnostic agents and analytical equipment including products utilizing the proprietary nucleic acid amplification method "LAMP"
3.Year 1xbet 라이브 방송 establishment: 20 February, 1939
4.Registered address: 33-8, Hongo 1-chome, Bunkyo-ku, Tokyo
5.President: Tadao Kurozumi
6.Share capital: ¥ 6,897 million
7.Total assets: ¥ 29,595 million (consolidated)
8.Net sales: ¥ 23,551 million (consolidated)
9.Number 1xbet 라이브 방송 employees: 616 (Group)
10.Main shareholders and percentage 1xbet 라이브 방송 ownership: The Master Trust 1xbet 라이브 방송 Japan, Ltd. 23.35%
(Tanabe Seiyaku Employees' Retirement Fund)
Japan Trustee Services Bank, Ltd. 15.01%
Hitachi High-Technologies Corp. 8.41%
Tadao Kurozumi 3.43%
1xbet 라이브 방송 Dai-Ichi Mutual Life Insurance Company 2.31%

4.Schedule

7 September, 2006:
- Approval 1xbet 라이브 방송 strategic partnership by the boards 1xbet 라이브 방송 Otsuka Pharmaceutical and Eiken Chemical

7 September, 2006:
- Signing 1xbet 라이브 방송 strategic partnership agreement

5.Forward-look1xbet 라이브 방송g 1xbet 라이브 방송formation

Both Otsuka Pharmaceutical and Eiken Chemical are currently dedicating their highest efforts to conclude co-operation agreements for specific product and development areas. The potential financial impact 1xbet 라이브 방송 these co-operations is still being evaluated and further details will be disclosed in due course.